2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …
M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …
detailed information, the user should always access to the full text version of the guidelines …
Heart failure with mid-range or mildly reduced ejection fraction
G Savarese, D Stolfo, G Sinagra, LH Lund - Nature Reviews Cardiology, 2022 - nature.com
Left ventricular ejection fraction (EF) remains the major parameter for diagnosis,
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
phenotyping, prognosis and treatment decisions in heart failure. The 2016 ESC heart failure …
Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport …
A Pelliccia, EE Solberg, M Papadakis… - European Heart …, 2019 - academic.oup.com
Myocardial diseases are associated with an increased risk of potentially fatal cardiac
arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic …
arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic …
Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy
A Di Marco, PF Brown, J Bradley, G Nucifora… - Journal of the American …, 2021 - jacc.org
Background Risk stratification for ventricular arrhythmias (VA) and sudden death in
nonischemic dilated cardiomyopathy (DCM) remains suboptimal. Objectives The goal of this …
nonischemic dilated cardiomyopathy (DCM) remains suboptimal. Objectives The goal of this …
Role of cardiac magnetic resonance in the diagnosis and prognosis of nonischemic cardiomyopathy
Cardiac magnetic resonance (CMR) is a valuable tool for the evaluation of patients with, or
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …
at risk for, heart failure and has a growing impact on diagnosis, clinical management, and …
Outcome in dilated cardiomyopathy related to the extent, location, and pattern of late gadolinium enhancement
BP Halliday, AJ Baksi, A Gulati, A Ali… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: This study sought to investigate the association between the extent, location, and
pattern of late gadolinium enhancement (LGE) and outcome in a large dilated …
pattern of late gadolinium enhancement (LGE) and outcome in a large dilated …
Imaging and impact of myocardial fibrosis in aortic stenosis
Aortic stenosis is characterized both by progressive valve narrowing and the left ventricular
remodeling response that ensues. The only effective treatment is aortic valve replacement …
remodeling response that ensues. The only effective treatment is aortic valve replacement …
The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy: a review and meta-analysis
MAJ Becker, JH Cornel, PM Van de Ven… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This review and meta-analysis reviews the prognostic value of cardiac magnetic
resonance (CMR) in nonischemic dilated cardiomyopathy (DCM). Background: Late …
resonance (CMR) in nonischemic dilated cardiomyopathy (DCM). Background: Late …
Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions
Heart failure (HF) with borderline ejection fraction was first defined in 2013 in the American
College of Cardiology/American Heart Association guidelines as the presence of the typical …
College of Cardiology/American Heart Association guidelines as the presence of the typical …
Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy
Background: Nonischemic cardiomyopathy is a leading cause of reduced left ventricular
ejection fraction (LVEF) and is associated with high mortality risk from progressive heart …
ejection fraction (LVEF) and is associated with high mortality risk from progressive heart …